INMD
Price
$14.90
Change
+$0.12 (+0.81%)
Updated
Sep 26 closing price
Capitalization
941.82M
25 days until earnings call
XVIPF
Price
$19.05
Change
+$0.05 (+0.26%)
Updated
Sep 22 closing price
Capitalization
562.29M
Interact to see
Advertisement

INMD vs XVIPF

Header iconINMD vs XVIPF Comparison
Open Charts INMD vs XVIPFBanner chart's image
InMode
Price$14.90
Change+$0.12 (+0.81%)
Volume$488.46K
Capitalization941.82M
Xvivo Perfusion AB
Price$19.05
Change+$0.05 (+0.26%)
Volume$153
Capitalization562.29M
INMD vs XVIPF Comparison Chart in %
Loading...
INMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XVIPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INMD vs. XVIPF commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INMD is a StrongBuy and XVIPF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (INMD: $14.90 vs. XVIPF: $19.05)
Brand notoriety: INMD and XVIPF are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: INMD: 49% vs. XVIPF: 18%
Market capitalization -- INMD: $941.82M vs. XVIPF: $562.29M
INMD [@Medical/Nursing Services] is valued at $941.82M. XVIPF’s [@Medical/Nursing Services] market capitalization is $562.29M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.44B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INMD’s FA Score shows that 0 FA rating(s) are green whileXVIPF’s FA Score has 0 green FA rating(s).

  • INMD’s FA Score: 0 green, 5 red.
  • XVIPF’s FA Score: 0 green, 5 red.
According to our system of comparison, INMD is a better buy in the long-term than XVIPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INMD’s TA Score shows that 5 TA indicator(s) are bullish while XVIPF’s TA Score has 3 bullish TA indicator(s).

  • INMD’s TA Score: 5 bullish, 3 bearish.
  • XVIPF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, INMD is a better buy in the short-term than XVIPF.

Price Growth

INMD (@Medical/Nursing Services) experienced а +1.36% price change this week, while XVIPF (@Medical/Nursing Services) price change was +0.28% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.97%. For the same industry, the average monthly price growth was +2.80%, and the average quarterly price growth was +8.73%.

Reported Earning Dates

INMD is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Medical/Nursing Services (-1.97% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INMD($942M) has a higher market cap than XVIPF($562M). XVIPF has higher P/E ratio than INMD: XVIPF (51.05) vs INMD (6.26). INMD YTD gains are higher at: -10.778 vs. XVIPF (-53.644). XVIPF has higher annual earnings (EBITDA): 182M vs. INMD (115M). INMD has more cash in the bank: 511M vs. XVIPF (323M). INMD has less debt than XVIPF: INMD (6.1M) vs XVIPF (111M). XVIPF has higher revenues than INMD: XVIPF (823M) vs INMD (402M).
INMDXVIPFINMD / XVIPF
Capitalization942M562M168%
EBITDA115M182M63%
Gain YTD-10.778-53.64420%
P/E Ratio6.2651.0512%
Revenue402M823M49%
Total Cash511M323M158%
Total Debt6.1M111M5%
FUNDAMENTALS RATINGS
INMD vs XVIPF: Fundamental Ratings
INMD
XVIPF
OUTLOOK RATING
1..100
729
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
91
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
3784
PRICE GROWTH RATING
1..100
6192
P/E GROWTH RATING
1..100
8797
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INMD's Valuation (61) in the null industry is in the same range as XVIPF (91). This means that INMD’s stock grew similarly to XVIPF’s over the last 12 months.

INMD's Profit vs Risk Rating (100) in the null industry is in the same range as XVIPF (100). This means that INMD’s stock grew similarly to XVIPF’s over the last 12 months.

INMD's SMR Rating (37) in the null industry is somewhat better than the same rating for XVIPF (84). This means that INMD’s stock grew somewhat faster than XVIPF’s over the last 12 months.

INMD's Price Growth Rating (61) in the null industry is in the same range as XVIPF (92). This means that INMD’s stock grew similarly to XVIPF’s over the last 12 months.

INMD's P/E Growth Rating (87) in the null industry is in the same range as XVIPF (97). This means that INMD’s stock grew similarly to XVIPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INMDXVIPF
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
41%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
54%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
38%
MACD
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
42%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
43%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
51%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 19 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
INMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XVIPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMIEX16.780.10
+0.60%
MM S&P 500® Index Svc
WVALX51.540.27
+0.53%
Weitz Large Cap Equity-Investor Cl
CFGIX18.520.03
+0.16%
Cromwell Foresight Global Infras Instl
PAPTX11.230.01
+0.09%
PACE Alternative Strategies P2
OMSIX65.49N/A
N/A
Invesco Main Street R6

INMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMD has been loosely correlated with ENOV. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INMD jumps, then ENOV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMD
1D Price
Change %
INMD100%
+0.81%
ENOV - INMD
48%
Loosely correlated
-0.10%
ITGR - INMD
47%
Loosely correlated
-0.27%
CRL - INMD
45%
Loosely correlated
+2.05%
RVTY - INMD
45%
Loosely correlated
+1.23%
CNMD - INMD
45%
Loosely correlated
+0.02%
More

XVIPF and

Correlation & Price change

A.I.dvisor tells us that XVIPF and INMD have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XVIPF and INMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XVIPF
1D Price
Change %
XVIPF100%
N/A
INMD - XVIPF
20%
Poorly correlated
+0.81%
LUNG - XVIPF
8%
Poorly correlated
+1.75%
VPTDF - XVIPF
7%
Poorly correlated
-4.16%
OM - XVIPF
6%
Poorly correlated
-1.29%
USAQ - XVIPF
4%
Poorly correlated
+22.22%
More